Company: NCEL
Filing Date: 2025-06-23
Form Type: F-4/A
Source: 0001213900-25-056787
Chunk: 245

Company: NewcelX Ltd.
Filing Date: 2025-06-23
Form: F-4/A
Chunk 245
---
 You may vote “FOR,” “AGAINST” or “ABSTAIN” on Proposal 7. A failure to vote, an abstention or a broker non -vote, if any, will have the same effect as a vote “AGAINST” Proposal 7. THE NLS BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE
“FOR” PROPOSAL 7. 113 APPROVAL OF AMENDMENT TO THE ARTICLES TO CHANGE THE COMPANY NAME (PROPOSAL 8) At the extraordinary shareholders’ meeting, shareholders will be asked to approve the change of name of NLS from NLS Pharmaceutics Ltd. (Swiss name: NLS Pharmaceuticals AG) to “NewcelX Ltd.” (Swiss name: “NewcelX AG” and “NewcelX SA”), effective from the Effective Time. We seek the name change to reflect that the prior business has changed its business focus. Our new name shows the new emphasis of our Company on stem cell therapies. We will receive a new trading symbol for our Company as soon as we have changed our name. To approve this Proposal8, a resolution passed by a Simple Majority Vote is required. You may vote “FOR,” “AGAINST” or “ABSTAIN” on Proposal 8. A failure to vote, an abstention or a broker non -vote, if any, will have the same effect as a vote “AGAINST” Proposal 8. THE NLS BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE
“FOR” PROPOSAL 8. 114 Election of the new board of directors (PROPOSAL 9) According to Section 6.2.8 of the Merger Agreement, the current members of the NLS Board are required to resign from their positions (other than Alexander Zwyer and Olivier Samuel) prior to the effectiveness of the Merger and the Company is required to seek approval of its shareholders to elect a new NLS Board as designated by Kadimastem, which election shall enter into effect contingent upon the effective time of the Merger. Kadimastem has submitted the candidacy of Mr. Ronen Twito as new chairman of the NLS Board and Mr. Michel Revel, Mr. Eran Iohan, Ms. Liora Oren and Ms. Tammy Galili as new directors. At the extraordinary shareholders’ meeting, shareholders of the Company will be asked to elect Mr. Ronen Twito as a member and